nimbolide has been researched along with Respiratory Distress Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godugu, C; Pooladanda, V; Sunnapu, O; Talluri, MVNK; Thatikonda, S; Tiwary, S; Vemula, PK | 1 |
| Bale, S; Bathini, NB; Godugu, C; Pattnaik, B; Pooladanda, V; Sigalapalli, DK; Singh, SB; Thatikonda, S | 1 |
2 other study(ies) available for nimbolide and Respiratory Distress Syndrome
| Article | Year |
|---|---|
iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Drug Delivery Systems; Endotoxins; Humans; Limonins; Liposomes; Lung; Male; Mice; Mice, Inbred C57BL; Oligopeptides; RAW 264.7 Cells; Respiratory Distress Syndrome | 2021 |
Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation.
Topics: Animals; Azadirachta; Disease Models, Animal; Humans; Limonins; Male; Mice; Molecular Docking Simulation; NF-kappa B; Respiratory Distress Syndrome; Translocation, Genetic; Tumor Necrosis Factor-alpha | 2019 |